ANTI-C-MET ANTIBODY DRUG CONJUGATES
Search Report
EP4656248A3
Kind: A3
Mar 18, 2026
Applicants
AbbVie Manufacturing Management Unlimited Company
Inventors
PHILLIPS, Andrew C, REILLY, Regina M., DOHERTY, George A., JI, Cheng, BRUNCKO, Milan, BOGHAERT, Erwin R., ANDERSON, Mark
Abstract
The present disclosure provides c-Met antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
IPC Classifications
C07K 16/28 20060101AFI20260206BHEP
A61K 47/68 20170101ALI20260206BHEP
C07D 491/22 20060101ALI20260206BHEP
C07D 317/44 20060101ALI20260206BHEP
C07D 317/70 20060101ALI20260206BHEP
A61P 35/00 20060101ALI20260206BHEP
C07K 5/062 20060101ALI20260206BHEP
C07K 5/09 20060101ALI20260206BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR